Literature DB >> 8535240

Posttranslational modifications of bovine osteopontin: identification of twenty-eight phosphorylation and three O-glycosylation sites.

E S Sørensen1, P Højrup, T E Petersen.   

Abstract

Osteopontin (OPN) is a multiphosphorylated glycoprotein found in bone and other normal and malignant tissues, as well as in the physiological fluids urine and milk. The present study demonstrates that bovine milk osteopontin is phosphorylated at 27 serine residues and 1 threonine residue. Phosphoamino acids were identified by a combination of amino acid analysis, sequence analysis of S-ethylcysteine-derivatized phosphopeptides, and mass spectrometric analysis. Twenty-five phosphoserines and one phosphothreonine were located in Ser/Thr-X-Glu/Ser(P)/Asp motifs, and two phosphoserines were found in the sequence Ser-X-X-Glu/Ser(P). These sequence motifs are identical with the recognition sequences of mammary gland casein kinase and casein kinase II, respectively. Examination of the phosphorylation pattern revealed that the phosphorylations were clustered in groups of approximately three spanned by unphosphorylated regions of 11-32 amino acids. This pattern is probably of importance in the multiple functions of OPN involving interaction with Ca2+ and inorganic calcium salts. Furthermore, three O-glycosylated threonines (Thr 115, Thr 124, and Thr 129) have been identified in a threonine- and proline-rich region of the protein. Three putative N-glycosylation sites (Asn 63, Asn 85, and Asn 193) are present in bovine osteopontin, but sequence and mass spectrometric analysis showed that none of these asparagines were glycosylated in bovine mammary gland osteopontin. Alignment analysis showed that the majority of the phosphorylation sites in bovine osteopontin as well as all three O-glycosylation sites were conserved in other mammalian sequences. This conservation of serines, even in otherwise less well-conserved regions of the protein, indicates that the phosphorylation of osteopontin at specific sites is essential for the function of the protein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8535240      PMCID: PMC2142990          DOI: 10.1002/pro.5560041009

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  37 in total

1.  Sequence analysis of phosphoserine-containing peptides. Modification for picomolar sensitivity.

Authors:  H E Meyer; E Hoffmann-Posorske; H Korte; L M Heilmeyer
Journal:  FEBS Lett       Date:  1986-08-11       Impact factor: 4.124

2.  Properties of casein kinase from lactating bovine mammary gland.

Authors:  E W Bingham; M L Groves
Journal:  J Biol Chem       Date:  1979-06-10       Impact factor: 5.157

3.  Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence.

Authors:  A Oldberg; A Franzén; D Heinegård
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

4.  Purification and partial characterization of small proteoglycans I and II, bone sialoproteins I and II, and osteonectin from the mineral compartment of developing human bone.

Authors:  L W Fisher; G R Hawkins; N Tuross; J D Termine
Journal:  J Biol Chem       Date:  1987-07-15       Impact factor: 5.157

5.  Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation.

Authors:  D R Senger; C A Perruzzi; C F Gracey; A Papadopoulos; D G Tenen
Journal:  Cancer Res       Date:  1988-10-15       Impact factor: 12.701

6.  Molecular cloning of a tumor promoter-inducible mRNA found in JB6 mouse epidermal cells: induction is stable at high, but not at low, cell densities.

Authors:  J H Smith; D T Denhardt
Journal:  J Cell Biochem       Date:  1987-05       Impact factor: 4.429

7.  Isolation, characterization, and biosynthesis of a phosphorylated glycoprotein from rat bone.

Authors:  C W Prince; T Oosawa; W T Butler; M Tomana; A S Bhown; M Bhown; R E Schrohenloher
Journal:  J Biol Chem       Date:  1987-02-25       Impact factor: 5.157

8.  Immunohistochemical demonstration of a 44-KD phosphoprotein in developing rat bones.

Authors:  M P Mark; C W Prince; T Oosawa; S Gay; A L Bronckers; W T Butler
Journal:  J Histochem Cytochem       Date:  1987-07       Impact factor: 2.479

9.  The roles of autophosphorylation and phosphorylation in the life of osteopontin.

Authors:  R A Saavedra
Journal:  Bioessays       Date:  1994-12       Impact factor: 4.345

10.  A comparative immunocytochemical study on the subcellular distributions of 44 kDa bone phosphoprotein and bone gamma-carboxyglutamic acid (Gla)-containing protein in osteoblasts.

Authors:  M P Mark; C W Prince; S Gay; R L Austin; M Bhown; R D Finkelman; W T Butler
Journal:  J Bone Miner Res       Date:  1987-08       Impact factor: 6.741

View more
  53 in total

1.  Tartrate-resistant purple acid phosphatase is synthesized as a latent proenzyme and activated by cysteine proteinases.

Authors:  J Ljusberg; B Ek-Rylander; G Andersson
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

2.  Pre- and post-translational regulation of osteopontin in cancer.

Authors:  Pieter H Anborgh; Jennifer C Mutrie; Alan B Tuck; Ann F Chambers
Journal:  J Cell Commun Signal       Date:  2011-04-26       Impact factor: 5.782

3.  Isoform-specific O-glycosylation of osteopontin and bone sialoprotein by polypeptide N-acetylgalactosaminyltransferase-1.

Authors:  Hazuki E Miwa; Thomas A Gerken; Oliver Jamison; Lawrence A Tabak
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

4.  Overlapping functions of bone sialoprotein and pyrophosphate regulators in directing cementogenesis.

Authors:  M Ao; M B Chavez; E Y Chu; K C Hemstreet; Y Yin; M C Yadav; J L Millán; L W Fisher; H A Goldberg; M J Somerman; B L Foster
Journal:  Bone       Date:  2017-09-01       Impact factor: 4.398

5.  Phosphoserine--a convenient compound for modification of calcium phosphate bone cement collagen composites.

Authors:  A Reinstorf; M Ruhnow; M Gelinsky; W Pompe; U Hempel; K W Wenzel; P Simon
Journal:  J Mater Sci Mater Med       Date:  2004-04       Impact factor: 3.896

Review 6.  The role of osteopontin in kidney diseases.

Authors:  Beata Kaleta
Journal:  Inflamm Res       Date:  2018-11-19       Impact factor: 4.575

7.  Roles of electrostatics and conformation in protein-crystal interactions.

Authors:  Paul V Azzopardi; Jason O'Young; Gilles Lajoie; Mikko Karttunen; Harvey A Goldberg; Graeme K Hunter
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

8.  Effects of osteopontin inhibition on radiosensitivity of MDA-MB-231 breast cancer cells.

Authors:  Antje Hahnel; Henri Wichmann; Matthias Kappler; Matthias Kotzsch; Dirk Vordermark; Helge Taubert; Matthias Bache
Journal:  Radiat Oncol       Date:  2010-09-17       Impact factor: 3.481

9.  Osteopontin is cleaved at multiple sites close to its integrin-binding motifs in milk and is a novel substrate for plasmin and cathepsin D.

Authors:  Brian Christensen; Lotte Schack; Eva Kläning; Esben S Sørensen
Journal:  J Biol Chem       Date:  2010-01-13       Impact factor: 5.157

10.  The role of osteopontin in inflammatory processes.

Authors:  Susan Amanda Lund; Cecilia M Giachelli; Marta Scatena
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.